Laureate Pharma, Inc. and Iconic Therapeutics, Inc. Announce Production of Clinical Material

PRINCETON, N.J., and ATLANTA, Jan. 7 /PRNewswire/ -- Laureate Pharma, Inc., a full-service biopharmaceutical development and protein production company specializing in the development and GMP manufacture of monoclonal antibodies, fusion proteins and other therapeutic protein products, and Iconic Therapeutics, a company focused on the development of treatments for wet adult macular degeneration (wet AMD) and other ophthalmic diseases, today announced the completion of the manufacture of the first GMP lot of hI-con1(TM) recombinant Fc-Factor VII fusion protein.

Back to news